Provided by Tiger Trade Technology Pte. Ltd.

Indaptus Therapeutics, Inc.

2.39
+0.310014.90%
Volume:272.13K
Turnover:597.71K
Market Cap:317.87M
PE:-5.08
High:2.40
Open:2.00
Low:1.97
Close:2.08
52wk High:8.57
52wk Low:0.9200
Shares:133.00M
Float Shares:23.24M
Volume Ratio:2.98
T/O Rate:1.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4709
EPS(LYR):-21.5800
ROE:-318.04%
ROA:-98.08%
PB:27.95
PE(LYR):-0.11

Loading ...

Mar 13, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 13, 2025

Correspondence

Form CORRESP - Correspondence
Feb 12, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Feb 12, 2025

Major Issues Report

Form 8-K - Current report
Feb 11, 2025

Correspondence

Form CORRESP - Correspondence
Jan 31, 2025

Major Issues Report

Form 8-K - Current report
Jan 15, 2025

Major Issues Report

Form 8-K - Current report
Dec 30, 2024

Correspondence

Form CORRESP - Correspondence
Dec 23, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Nov 26, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Nov 22, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Oct 22, 2024

Major Issues Report

Form 8-K - Current report
Oct 10, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Sep 18, 2024

Correspondence

Form CORRESP - Correspondence
Sep 12, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Aug 12, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2024

Major Issues Report

Form 8-K - Current report